Published in Endocrinology on September 01, 1977
An investigation of sites that bind human somatotropin (growth hormone) in the liver of the pregnant rabbit. Biochem J (1981) 1.10
Characteristics of solubilized human-somatotropin-binding protein from the liver of pregnant rabbits. Biochem J (1980) 1.03
Characterization of human somatotropin binding to detergent-solubilized lactogenic receptors from rat liver. Biochem J (1981) 0.87
Identification of a rabbit liver cytosolic binding protein for human growth hormone. Biochem J (1984) 0.87
Purification of a prolactin receptor. Proc Natl Acad Sci U S A (1982) 0.85
Characterization of prolactin receptors in pig mammary gland. Biochem J (1984) 0.80
The specificity of binding of growth hormone and prolactin to purified plasma membranes from pregnant-rabbit liver. Biochem J (1986) 0.78
Structural studies on membrane-bound and soluble growth-hormone-binding proteins of rabbit liver. Biochem J (1987) 0.75
Stimulation of proteoglycan biosynthesis by serum and insulin-like growth factor-I in cultured bovine articular cartilage. Biochem J (1986) 1.51
Guinea pig serum contains a specific high affinity growth hormone-binding protein with novel ligand specificity. Endocrinology (1997) 1.38
The regulation of growth by endocrines. Annu Rev Physiol (1975) 1.26
The expression of the ADAMs proteases in prostate cancer cell lines and their regulation by dihydrotestosterone. Mol Cell Endocrinol (2000) 1.23
Evidence for the selection by the membrane transport system of intracellular or extracellular amino acids for protein synthesis. Biochim Biophys Acta (1972) 1.17
Human adipose tissue endothelial cells promote preadipocyte proliferation. Am J Physiol Endocrinol Metab (2001) 1.16
Evidence for the specific binding of growth hormone to a receptor-like protein in rabbit serum. Mol Cell Endocrinol (1985) 1.08
Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines. Endocr Relat Cancer (2005) 1.07
Identification and characterization of specific binding proteins for growth hormone in normal human sera. J Clin Invest (1986) 1.07
Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells. Endocr Relat Cancer (2005) 1.06
Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines. J Endocrinol (2002) 1.04
Recent advances in the biochemistry and physiology of the insulin-like growth factor/somatomedin family. Int J Biochem (1983) 1.03
A potential autocrine pathway for growth hormone releasing hormone (GHRH) and its receptor in human prostate cancer cell lines. Prostate (2001) 1.03
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 are key regulators of extracellular matrix degradation by mouse embryos. Biol Reprod (2001) 0.96
Expression of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in normal human testis and testicular tumors. J Clin Endocrinol Metab (2004) 0.94
Localization of insulin-like growth factor-I mRNA in rat brain by in situ hybridization--relationship to IGF-I receptors. Mol Endocrinol (1990) 0.93
Characterization of the binding of human growth hormone to microsomal membranes from rat liver. Biochem J (1976) 0.92
Effects of rosiglitazone and linoleic acid on human preadipocyte differentiation. Eur J Clin Invest (2003) 0.92
Coffee contains potent opiate receptor binding activity. Nature (1983) 0.92
Effects of free and bound insulin-like growth factors on proteoglycan metabolism in articular cartilage explants. J Orthop Res (1992) 0.92
Immunolocalization of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in the cyclic human ovary. J Clin Endocrinol Metab (2003) 0.91
Cellular mechanisms in the processing of growth hormone and its receptor. Mol Cell Endocrinol (1989) 0.90
The biological and structural characterization of specific serum binding proteins for the insulin-like growth factors. J Endocrinol (1988) 0.90
Intracellular processing of growth hormone receptors by adipocytes in primary culture. Mol Cell Endocrinol (1988) 0.89
Pituitary regulation of human growth hormone binding sites in rat liver membranes. Metabolism (1976) 0.89
Growth hormone-binding proteins in high-speed cytosols of multiple tissues of the rabbit. Biochim Biophys Acta (1986) 0.88
Cloning and characterization of the growth hormone-dependent insulin-like growth factor binding protein (IGFBP-3) in the rat. Biochem Biophys Res Commun (1990) 0.88
Co-expression of GH and GHR isoforms in prostate cancer cell lines. Growth Horm IGF Res (2002) 0.87
Messenger ribonucleic acid expression of the insulin-like growth factors and their binding proteins in uterine fibroids and myometrium. J Clin Endocrinol Metab (1993) 0.87
Identification of a specific inhibitor of nonsuppressible insulin-like activity in a partially purified human serum fraction. Endocrinology (1981) 0.87
Identification of a rabbit liver cytosolic binding protein for human growth hormone. Biochem J (1984) 0.87
Insulin-like growth factor characteristics of an acidic non-suppressible insulin-like activity. Biochem J (1984) 0.86
Partial purification of low molecular weight non-suppressible insulin-like activity from human plasma: demonstration of the presence of multiple forms. J Endocrinol (1980) 0.86
Water soluble receptors for human growth hormone from rabbit liver. J Recept Res (1981) 0.86
Detailed assessment of big big prolactin in women with hyperprolactinemia and normal ovarian function. J Clin Endocrinol Metab (1989) 0.86
Covalent cross-linking of insulin-like growth factor-1 to a specific inhibitor from human serum. Biochem Biophys Res Commun (1986) 0.86
Steroid hormone effects on sonatomedin. I. Somatomedin action in vitro. Endocrinology (1975) 0.86
Proteolytic conversion of insulin-like growth factors to an acidic form(s). Biochem J (1984) 0.86
Radioreceptor and radioimmunoassay quantitation of human growth hormone in acromegalic serum: overestimation by immunoassay and systematic differences between antisera. J Clin Endocrinol Metab (1974) 0.85
Comparison of somatomedin activity in perfusates of normal and hypophysectomized rat livers with and without added growth hormone. Endocrinology (1976) 0.85
Demonstration and localization of growth hormone receptor in human skin and skin fibroblasts. J Clin Endocrinol Metab (1992) 0.85
Hepatic binding of human and bovine growth hormones and ovine prolactin in the dwarf "little" mouse. Endocrinology (1983) 0.85
Expression of the ghrelin axis in the mouse: an exon 4-deleted mouse proghrelin variant encodes a novel C terminal peptide. Endocrinology (2004) 0.84
Prolactin in human milk: correlation with lactose, total protein, and alpha-lactalbumin levels. Am J Physiol (1980) 0.83
Water-soluble hepatic growth hormone receptors: structural studies using gel chromatography and chemical cross-linking. Endocrinology (1984) 0.83
Insulin-like growth factors: biochemistry and physiology. Baillieres Clin Endocrinol Metab (1991) 0.83
Expression of growth hormone secretagogue receptor type 1a, the functional ghrelin receptor, in human ovarian surface epithelium, mullerian duct derivatives, and ovarian tumors. J Clin Endocrinol Metab (2004) 0.81
Identification of an insulin-responsive element in the rat insulin-like growth factor-binding protein-3 gene. J Biol Chem (1997) 0.81
Growth hormone receptors in cultured adipocytes: a model to study receptor regulation. Mol Cell Endocrinol (1986) 0.81
Identification of growth hormone receptors on human growth plate chondrocytes. Acta Paediatr Suppl (1993) 0.81
Developmental expression of the growth hormone receptor gene in rabbit tissues. Mol Cell Endocrinol (1992) 0.81
Preferential association of the insulin-like growth factors I and II with metabolically inactive and active carrier-bound complexes in serum. Biochem J (1987) 0.80
Messenger RNA encoding the insulin-like growth factors and their binding proteins, in women with fibroids, pretreated with luteinizing hormone-releasing hormone agonists. Hum Reprod (1994) 0.80
Tissue distribution, characterization, and regulation of messenger ribonucleic acid for growth hormone receptor and serum binding protein in the rat. Endocrinology (1991) 0.80
The occurrence of a distinct high molecular weight form of serum non-suppressible insulin-like activity. Mol Cell Endocrinol (1979) 0.80
Steroid receptor binding and messenger RNA expression in fibroids from untreated and gonadotrophin-releasing hormone agonist pretreated women. Clin Endocrinol (Oxf) (1994) 0.80
Partial purification of a specific inhibitor of the insulin-like growth factors by reversed-phase high-performance liquid chromatography. J Chromatogr (1984) 0.79
Specific non-saturable binding of insulin by human platelets. Mol Cell Endocrinol (1985) 0.79
Affinity purification and structural characterization of a specific binding protein for human growth hormone in human serum. Biochem Biophys Res Commun (1986) 0.79
The heparin binding domain of insulin-like growth factor binding protein (IGFBP)-3 increases susceptibility of IGFBP-3 to proteolysis. Horm Metab Res (1999) 0.79
Somatomedin stimulation of sulfate incorporation in porcine costal cartilage discs. Endocrinology (1974) 0.79
Deficiency of non-suppressible insulin-like activity in thalassaemia major. Arch Dis Child (1981) 0.79
Insulin-like growth factor-I and its autocrine role in growth of MCF-7 human breast cancer cells in culture. J Mol Endocrinol (1989) 0.78
Evidence for a biologically active, carrier-bound form of non-suppressible insulin-like activity (NSILA) in human serum. Int J Biochem (1983) 0.78
Tissue distribution and regulation of insulin-like growth factor (IGF)-binding protein-3 messenger ribonucleic acid (mRNA) in the rat: comparison with IGF-I mRNA expression. Endocrinology (1992) 0.78
The presence of lactogen receptors in human chorion laeve. J Clin Endocrinol Metab (1980) 0.78
Studies on the possible mechanism for deficiency of nonsuppressible insulin-like activity in thalassemia major. J Clin Endocrinol Metab (1981) 0.78
Differentiation between carrier-bound forms of non-suppressible insulin-like activity (NSILA) in serum. Int J Biochem (1985) 0.78
Chronic idiopathic polyhydramnios: evidence for a defect in the chorion laeve receptor for lactogenic hormones. J Clin Endocrinol Metab (1983) 0.78
Growth hormone and insulin-like growth factor-I accelerate PMSG-induced differentiation of granulosa cells. Mol Cell Endocrinol (1988) 0.77
Interaction between the hepatic growth hormone receptor and concanavalin A. Mol Cell Endocrinol (1979) 0.77
Recognition of insulin-like growth factor (IGF) serum binding proteins by an antibody raised against a specific IGF-inhibitor. Biochem Biophys Res Commun (1988) 0.77
Effect of disulfide-bond reducing agents on the specific binding of growth hormone to microsomal membrane preparations from rabbit liver. Biochem Pharmacol (1986) 0.77
Urokinase-type plasminogen activator (uPA) and matrix metalloproteinase-9 (MMP-9) expression and activity during early embryo development in the cow. Anat Embryol (Berl) (2001) 0.77
Processing of growth hormone by rat adipocytes in primary culture: differentiation between release of intact hormone and degradative processing. Endocrinology (1987) 0.77
Epidermal growth factor and transforming growth factor-beta in uterine fibroids and myometrium. Gynecol Obstet Invest (1995) 0.77
Effect of zinc on insulin binding to rat adipocytes and hepatic membranes and to human placental membranes and IM-9 lymphocytes. Horm Metab Res (1985) 0.77
Measurement of somatomedin by cartilage in vitro. Methods Enzymol (1975) 0.77
Effect of zinc on the binding and action of growth hormone in isolated rat adipocytes. Biochem Int (1985) 0.77
The presence of lactogen but not growth hormone binding sites in the isolated rat hepatocyte. J Endocrinol (1977) 0.76
Divergent ileal IGF-I and IGFBP-3 gene expression after small bowel resection: a novel mechanism to amplify IGF action? Mol Cell Endocrinol (1992) 0.76
Focal induction of IGF binding proteins in proximal tubules of diabetic rat kidney. Diabetes (1992) 0.76
Receptor-mediated endocytosis and degradative processing of growth hormone by rat adipocytes in primary culture. Endocrinology (1987) 0.76
Cloning and characterization of the promoter for the rat insulin-like growth factor-binding protein-3 gene. Endocrinology (1995) 0.76
Binding of human growth hormone to hepatic lactogenic binding sites: regulation by oestrogens and androgens. J Endocrinol (1976) 0.76
Direct inhibition of rat granulosa cell inhibin production by epidermal growth factor in vitro. Mol Cell Endocrinol (1987) 0.76
Kidney insulin-like growth factor-I mRNA levels are increased in postpubertal diabetic rats. J Endocrinol (1991) 0.76
Ontogeny of messenger RNA for the rat growth hormone receptor and serum binding protein. Mol Cell Endocrinol (1992) 0.76
Lack of response of nonsuppressible insulin-like activity to short term administration of human growth hormone in thalassemia major. J Clin Endocrinol Metab (1981) 0.76
Growth factors in ovarian function. J Reprod Fertil (1989) 0.75
Recognition of insulin-like-growth-factor-binding proteins in serum and amniotic fluid by an antiserum against a low-molecular-mass insulin-like-growth-factor-inhibitor/binding protein. Biochem J (1990) 0.75
Binding and structural characteristics of a soluble lactogen-binding protein from rabbit mammary-gland cytosol. Biochem J (1986) 0.75
Structural studies on membrane-bound and soluble growth-hormone-binding proteins of rabbit liver. Biochem J (1987) 0.75
Opiate binding sites in bovine adrenal medulla. J Recept Res (1983) 0.75
Postreceptor signaling mechanisms for Growth Hormone. Trends Endocrinol Metab (2008) 0.75
Chronic polyhydramnios is a syndrome with a lactogen receptor defect in the chorion laeve. Br J Obstet Gynaecol (1985) 0.75
Isolation of insulin-like growth Factors I and II from human plasma. Prep Biochem (1984) 0.75
Characterization of a soluble prolactin-binding activity in rat liver cytosol. J Endocrinol (1986) 0.75